| scholarly article | Q13442814 |
| P2093 | author name string | Jun Liu | |
| Wenli Li | |||
| Zheng Chen | |||
| Rongfu Huang | |||
| Chunmei Fan | |||
| P2860 | cites work | Cdk5: multitasking between physiological and pathological conditions | Q24299163 |
| International network of cancer genome projects | Q24611474 | ||
| Functional properties of complement factor H-related proteins FHR-3 and FHR-4: binding to the C3d region of C3b and differential regulation by heparin | Q28141946 | ||
| limma powers differential expression analyses for RNA-sequencing and microarray studies | Q29617988 | ||
| Cyclin-dependent kinase 5 regulates endothelial cell migration and angiogenesis. | Q30497293 | ||
| Time-dependent ROC curves for censored survival data and a diagnostic marker | Q30600327 | ||
| Thrombospondin 1 promotes an aggressive phenotype through epithelial-to-mesenchymal transition in human melanoma | Q34221697 | ||
| The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge | Q35066321 | ||
| Insights into the clinical value of cyclin-dependent kinase 5 in glioma: a retrospective study | Q35886193 | ||
| clusterProfiler: an R package for comparing biological themes among gene clusters. | Q35920061 | ||
| Expression of Ferritin Light Chain (FTL) Is Elevated in Glioblastoma, and FTL Silencing Inhibits Glioblastoma Cell Proliferation via the GADD45/JNK Pathway | Q35922006 | ||
| Aberrant expression of CDK5 infers poor outcomes for nasopharyngeal carcinoma patients | Q36014280 | ||
| Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future. | Q36106006 | ||
| An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker | Q36560502 | ||
| Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma | Q90318358 | ||
| The prognostic landscape of tumor-infiltrating immune cells in cervical cancer | Q90343195 | ||
| Immunotherapy in hepatocellular carcinoma: the complex interface between inflammation, fibrosis, and the immune response | Q90806045 | ||
| Inhibition of enhancer of zest homologue 2 is a potential therapeutic target for high-MYC medulloblastoma | Q90994772 | ||
| Hepatocellular Carcinoma: Etiology and Current and Future Drugs | Q91525643 | ||
| Liver-Mediated Adaptive Immune Tolerance | Q91583964 | ||
| Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma | Q91675591 | ||
| Loss of enhancer of zeste homologue 2 (EZH2) at tumor invasion front is correlated with higher aggressiveness in colorectal cancer cells | Q91977949 | ||
| Immunostaining of Increased Expression of Enhancer of Zeste Homolog 2 (EZH2) in Diffuse Midline Glioma H3K27M-Mutant Patients with Poor Survival | Q92079633 | ||
| Prognostic nomogram based on immune scores for breast cancer patients | Q92163965 | ||
| Role of EZH2 in cell lineage determination and relative signaling pathways | Q92195107 | ||
| Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of colorectal cancer | Q92221181 | ||
| Wedelolactone Targets EZH2-mediated Histone H3K27 Methylation in Mantle Cell Lymphoma | Q92319042 | ||
| Disparity in Tumor Immune Microenvironment of Breast Cancer and Prognostic Impact: Asian Versus Western Populations | Q92351830 | ||
| Robust expression of EZH2 in endocervical neoplastic lesions | Q92566051 | ||
| Glypican-3-Specific CAR T Cells Coexpressing IL15 and IL21 Have Superior Expansion and Antitumor Activity against Hepatocellular Carcinoma | Q92738713 | ||
| Epidemiology and surveillance for hepatocellular carcinoma: New trends | Q92746895 | ||
| CXCR2-modified CAR-T cells have enhanced trafficking ability that improves treatment of hepatocellular carcinoma | Q92935558 | ||
| Inflammation associated anemia and ferritin as disease markers in SLE | Q36633384 | ||
| Molecular and genetic properties of tumors associated with local immune cytolytic activity | Q36869059 | ||
| Evaluation and clinical significance of cyclin-dependent kinase5 expression in cervical lesions: a clinical research study in Guangxi, China | Q37089878 | ||
| Comprehensive analyses of tumor immunity: implications for cancer immunotherapy | Q37193493 | ||
| CDK5 is essential for TGF-β1-induced epithelial-mesenchymal transition and breast cancer progression | Q37229083 | ||
| Genetic Landscape and Biomarkers of Hepatocellular Carcinoma. | Q38534459 | ||
| Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer | Q38688789 | ||
| Thrombospondin-1 Production Regulates the Inflammatory Cytokine Secretion in THP-1 Cells Through NF-κB Signaling Pathway | Q38716247 | ||
| Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma | Q38722204 | ||
| Hepatitis E virus ORF1 encoded macro domain protein interacts with light chain subunit of human ferritin and inhibits its secretion. | Q38771597 | ||
| The Emerging Role of Cdk5 in Cancer | Q39029140 | ||
| Biological functions of CDK5 and potential CDK5 targeted clinical treatments | Q39080473 | ||
| Thrombospondin-1 triggers cell migration and development of advanced prostate tumors. | Q39450850 | ||
| Oxidative stress and cell death in cells expressing L-ferritin variants causing neuroferritinopathy | Q39795199 | ||
| Relationships between typical histopathological hallmarks and the ferritin in the hippocampus from patients with Alzheimer's disease | Q39905458 | ||
| Ferritin as an early marker of graft rejection after allogeneic hematopoietic stem cell transplantation in pediatric patients | Q40269737 | ||
| Tumor-infiltrating, interleukin-33-producing effector-memory CD8(+) T cells in resected hepatocellular carcinoma prolong patient survival | Q41489558 | ||
| Thrombospondin-1 is highly expressed in desmoplastic components of invasive ductal carcinoma of the breast and associated with lymph node metastasis | Q44991742 | ||
| Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade. | Q45949028 | ||
| Iron metabolism disturbances in the MCF-7 human breast cancer cells with acquired resistance to doxorubicin and cisplatin | Q47719938 | ||
| Loss of Cdk5 in breast cancer cells promotes ROS-mediated cell death through dysregulation of the mitochondrial permeability transition pore. | Q48215901 | ||
| Estimation of serum ferritin level in potentially malignant disorders, oral squamous cell carcinoma, and treated cases of oral squamous cell carcinoma | Q50237285 | ||
| Inhibition of Cdk5 induces cell death of tumor-initiating cells. | Q50880834 | ||
| Correlation Between Thrombospondin-1 Expression in Non-cancer Tissue and Gastric Carcinogenesis. | Q50912532 | ||
| Thrombospondin-1 promotes mesenchymal stromal cell functions via TGFβ and in cooperation with PDGF. | Q51136254 | ||
| TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. | Q51768874 | ||
| Regulation and Function of the PD-L1 Checkpoint. | Q52725238 | ||
| FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis. | Q53572147 | ||
| Ferritin light chain gene mutation in a large Australian family with hereditary hyperferritinemia-cataract syndrome. | Q53813183 | ||
| High Complement Factor H-Related (FHR)-3 Levels Are Associated With the Atypical Hemolytic-Uremic Syndrome-Risk Allele CFHR3*B. | Q54217596 | ||
| Targeting cyclin dependent kinase 5 in hepatocellular carcinoma--A novel therapeutic approach. | Q55068022 | ||
| The immune contexture of hepatocellular carcinoma predicts clinical outcome. | Q55180095 | ||
| Effects of Enhancer of Zeste Homolog 2 (EZH2) Expression on Brain Glioma Cell Proliferation and Tumorigenesis | Q57281248 | ||
| Thrombospondin-1 expression in breast cancer: prognostic significance and association with p53 alterations, tumour angiogenesis and extracellular matrix components | Q57742707 | ||
| EZH2 promotes DNA replication by stabilizing interaction of POLδ and PCNA via methylation-mediated PCNA trimerization | Q58803907 | ||
| Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries | Q60142201 | ||
| Aberrant Epigenetic Regulation in Head and Neck Cancer Due to Distinct EZH2 Overexpression and DNA Hypermethylation | Q60950169 | ||
| Development of a prognostic index based on an immunogenomic landscape analysis of papillary thyroid cancer | Q61812749 | ||
| A two-stage microbial association mapping framework with advanced FDR control. | Q64998339 | ||
| Deletion of CFHR3 and CFHR1 genes in age-related macular degeneration | Q80209360 | ||
| Overexpression of thrombospondin-1 in stromal myofibroblasts is associated with tumor growth and nodal metastasis in gastric carcinoma | Q83199867 | ||
| Role of Foxp3-positive tumor-infiltrating lymphocytes in the histologic features and clinical outcomes of hepatocellular carcinoma | Q83740516 | ||
| Anti-proliferative benefit of curcumol on human bladder cancer cells via inactivating EZH2 effector | Q88934491 | ||
| Tumor-infiltrating CD8+ T cells combined with tumor-associated CD68+ macrophages predict postoperative prognosis and adjuvant chemotherapy benefit in resected gastric cancer | Q90106921 | ||
| P4510 | describes a project that uses | limma | Q112236343 |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P577 | publication date | 2020-02-24 | |
| P1433 | published in | International Journal of Oncology | Q6051527 |
| P1476 | title | Immune system‑associated genes increase malignant progression and can be used to predict clinical outcome in patients with hepatocellular carcinoma |
Search more.